Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.

The healthcare leader is also an excellent income stock. Johnson & Johnson has increased its dividend payout for 62 ...

To give some idea of the sheer size of Johnson & Johnson, a glance at its reported sales figure is revealing. In the fourth ...

Selling pharmaceutical products is a steady and reliable ... into pharmaceuticals following the separation of its consumer health segment, Johnson & Johnson's innovative capabilities will be ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp. (NVDA), Johnson & ...

In his new book, Afro Sheen, the legendary founder of the Johnson Products Company chronicles his creation of a business empire that spanned the Jim Crow era, the Civil Rights movement and the rise of ...

Johnson & Johnson (NYSE ... but somewhat clunky combination of classic pharmaceutical company and consumer healthcare products purveyor. That ended when it hived off the latter business as ...

The outdoor recreational products company swung to a net loss of $15.3 million, or $1.49 a share, in the three months ended Dec. 27, compared with a profit of $4 million, or 38 cents a share, in the ...

In life, dating can often be an investment – an investment of time, money, mental capacity, you name it. Inversely, in the finance realm, what if ...

Rising consumer demand for fewer empty calories is pushing the snack and beverage giant to offer options with less sodium, ...

Multinational healthcare company Johnson & Johnson (NYSE:JNJ) in Q4 CY2024, with sales up 5.3% year on year to $22.52 billion ...

Evolving the position of category manager to Ecommerce Category Manager, or eCatman, can help brands effectively navigate the ...